What to do about neonatal thalassemia

Neonatal thalassemia is a hereditary hemolytic anemia. Its treatment mainly includes the following aspects: 1. **Medication**: For neonates, deferoxamine mesylate injection may be administered under a doctor's guidance. After the age of two, medications such as deferasirox dispersible tablets may be taken orally to control the condition. 2. **Blood transfusion therapy**: If a neonate develops severe circulatory impairment or ischemia, blood transfusion therapy may be considered to improve the condition and enhance quality of life. 3. **Surgical treatment**: For children with severe disease, hematopoietic stem cell transplantation may be performed after the age of two, providing a fundamental treatment and preventing further disease progression. 4. **Dietary considerations**: Parents should also pay attention to the diet of the neonate, such as selecting iron-rich formulas, and mothers should consume iron-rich foods during breastfeeding. All medications should be used under the guidance of a doctor to ensure safety and effectiveness.